Skip to Main Content

Paper Details

Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer.
Oncoimmunology
18
2018

Datasets

Release 1.2